AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionBlackRock Variable Series Funds, Inc. - BlackRock Managed Volatility V.I. Fund Class I
Latest Disclosed Ownership3,452 shares
Latest Disclosed Value $ 640,760
BlackRock Variable Series Funds, Inc. - BlackRock Managed Volatility V.I. Fund Class I reports 0.23% increase in ownership of ABBV / AbbVie Inc.

On August 28, 2025 - BlackRock Variable Series Funds, Inc. - BlackRock Managed Volatility V.I. Fund Class I filed a NPORT-P form disclosing ownership of 3,452 shares of AbbVie Inc. (US:ABBV) valued at $640,760 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 27, 2025 disclosing 3,444 shares of AbbVie Inc.. This represents a change in shares of 0.23% during the quarter. The current value of the position is $685,947 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-28 2025-06-30 NP AbbVie EC US00287Y1091 3,452 8 0.23 641 -11.23 0.4219
2025-05-27 2025-03-31 NP AbbVie EC US00287Y1091 3,444 900 35.38 722 59.51 0.4815
2025-02-27 2024-12-31 NP AbbVie EC US00287Y1091 2,544 1,083 74.13 452 56.94 0.2794
2024-11-26 2024-09-30 NP AbbVie EC US00287Y1091 1,461 -483 -24.85 289 -13.51 0.1773
2024-08-27 2024-06-30 NP AbbVie EC US00287Y1091 1,944 -2,848 -59.43 333 -61.81 0.2017
2024-05-28 2024-03-31 NP AbbVie EC US00287Y1091 4,792 -314 -6.15 873 10.24 0.5097
2024-02-27 2023-12-31 NP AbbVie EC US00287Y1091 5,106 582 12.86 791 17.36 0.4746
2023-11-22 2023-09-30 NP AbbVie EC US00287Y1091 4,524 1,093 31.86 674 45.89 0.4057
2023-08-25 2023-06-30 NP AbbVie EC US00287Y1091 3,431 -1,761 -33.92 462 -44.14 0.2704
2023-05-26 2023-03-31 NP AbbVie EC US00287Y1091 5,192 115 2.27 827 0.85 0.4887
2023-02-24 2022-12-31 NP AbbVie EC US00287Y1091 5,077 -545 -9.69 820 8.75 0.4713
2022-11-28 2022-09-30 NP AbbVie EC US00287Y1091 5,622 -524 -8.53 755 -19.87 0.4430
2022-08-26 2022-06-30 NP AbbVie EC US00287Y1091 6,146 -659 -9.68 941 -14.69 0.5283
2022-05-25 2022-03-31 NP AbbVie EC US00287Y1091 6,805 1,091 19.09 1,103 42.69 0.5566
2022-02-25 2021-12-31 NP AbbVie EC US00287Y1091 5,714 210 3.82 774 30.35 0.3600
2021-11-26 2021-09-30 NP AbbVie EC US00287Y1091 5,504 1,199 27.85 594 22.52 0.2718
2021-08-24 2021-06-30 NP AbbVie EC US00287Y1091 4,305 104 2.48 485 6.61 0.2201
2021-05-25 2021-03-31 NP AbbVie EC US00287Y1091 4,201 -779 -15.64 455 -14.82 0.2073
2021-02-24 2020-12-31 NP AbbVie EC US00287Y1091 4,980 44 0.89 534 23.38 0.2385
2020-11-24 2020-09-30 NP AbbVie EC US00287Y1091 4,936 -938 -15.97 432 -25.00 0.2044
2020-08-24 2020-06-30 NP AbbVie EC US00287Y1091 5,874 -2,036 -25.74 577 -4.32 0.2762
2020-05-26 2020-03-31 NP AbbVie EC US00287Y1091 7,910 1,230 18.41 603 1.86 0.2968
2020-02-25 2019-12-31 NP AbbVie EC 00287Y109 6,680 -4,800 -41.81 591 -31.99 0.2504
2019-11-25 2019-09-30 NP AbbVie EC US00287Y1091 11,480 11,480 869 0.3698
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.